Register entry
Kowon International Korea Co., Ltd.
- Registered sites
- 1
- Drug products
- 5
- Live patents
- 0
- Countries
- 1
- Base
- South Korea
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Kowon International Korea Co., Ltd. | Chungbuk 27632South Korea | Active ingredient (API) manufacture | 3009717335 |
Catalogue
Marketed products
5Showing 5 of 5.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Titanium Dioxide | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Titanium Dioxide | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Titanium Dioxide | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Zinc Oxide | LIQUID | DRUG FOR FURTHER PROCESSING |
| - | Zinc Oxide | LIQUID | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.